Teneligliptin-D4

Development and validation of stability indicating RP-​HPLC method for teneligliptin hydrobromide hydrate
By Dahikar, Girish D.; Bobade, Gayatri
From American Journal of PharmTech Research (2021), 11(1), 1-12
 
Stability indicating LC-​assay method for metformin hydrochloride and teneligliptin hydrobromide from tablet formulations
By Basu, Arindam; Chakraborty, Jui
From International Journal of Pharmaceutical Sciences and Research (2020), 11(5), 2127-2134
 
Chemometric assisted method development for teneligliptin and metformin by stability indicating RP-​HPLC technique and its validation
By Devi, Dasari Vasavi; Swarnalatha, Dugasani; Reddy, Gopireddy Venkatasubba
From Asian Journal of Chemistry (2018), 30(12), 2704-2710
 

Teneligliptin-D4 is chemically ((2S,4S)-4-(4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl-2,2,6,6-d4)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone. Teneligliptin-D4 is supplied with detailed characterization data compliant with regulatory guideline. Teneligliptin-D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Teneligliptin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.